Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma

BACKGROUND: Endoglin (CD105) has been considered a prognostic marker for hepatocellular carcinoma (HCC), and widely used as an appropriate targeting for antiangenesis therapy in some cancers. Our aim was to evaluate the distribution and expression of CD105 in the liver of patients with HCC, and to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Decai, Zhuang, Linyuan, Sun, Xitai, Chen, Jun, Yao, Yongzhong, Meng, Kui, Ding, Yitao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941740/
https://www.ncbi.nlm.nih.gov/pubmed/17608955
http://dx.doi.org/10.1186/1471-2407-7-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941740/
https://www.ncbi.nlm.nih.gov/pubmed/17608955
http://dx.doi.org/10.1186/1471-2407-7-122

Ejemplares similares